Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 3. Determining factors of the proportion of class C in the hospital. (A) Relationship between the proportion of class C cases and the number of PCIs.

Published byGeorgina Spencer Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 3. Determining factors of the proportion of class C in the hospital. (A) Relationship between the proportion of class C cases and the number of PCIs."— Presentation transcript:

1 Fig. 3. Determining factors of the proportion of class C in the hospital. (A) Relationship between the proportion of class C cases and the number of PCIs performed in the hospital. (B) Relationship between the proportion of class C cases and the proportion of ACS cases in the hospital. The geographic region of the hospital is indicated as follows; Seoul as an open circle, Gyeonggi province as a gray circle, and other provinces as closed circles. PCI: percutaneous coronary intervention, ACS: acute coronary syndrome. Fig. 3. Determining factors of the proportion of class C in the hospital. (A) Relationship between the proportion of class C cases and the number of PCIs performed in the hospital. (B) Relationship between the proportion of class C cases and the proportion of ACS cases in the hospital. The geographic region of the hospital is indicated as follows; Seoul as an open… Korean Circ J May;47(3):

Download ppt "Fig. 3. Determining factors of the proportion of class C in the hospital. (A) Relationship between the proportion of class C cases and the number of PCIs."

Similar presentations

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
1 Canadian Institute for Health Information. Hospital Care for Heart Attacks Among First Nations, Inuit and Métis Released January 31, 2013 2.

1 Canadian Institute for Health Information. Hospital Care for Heart Attacks Among First Nations, Inuit and Métis Released January 31,
Ho PM, et al. JAMA 2009;301:937-44. Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:937-44.

Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:
Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.

Acute Coronary Syndromes SIGN 93. MINAP Mortality after Acute Coronary Syndromes Cumulative: 13.6% Blue 10.6% Green 11.6% Red.
Date of download: 7/5/2016 From: Validation of the Appropriate Use Criteria for Coronary Angiography: A Cohort Study Ann Intern Med. 2015;162(8):549-556.

Date of download: 7/5/2016 From: Validation of the Appropriate Use Criteria for Coronary Angiography: A Cohort Study Ann Intern Med. 2015;162(8):
Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Prognostic Importance of Physical Examination for.

Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Prognostic Importance of Physical Examination for.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.

Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.
Cost Savings Associated With Implementation of Peer-Reviewed Appropriate Use Criteria for Percutaneous Coronary Interventions  Pranav Puri, Jennifer Carroll,

Cost Savings Associated With Implementation of Peer-Reviewed Appropriate Use Criteria for Percutaneous Coronary Interventions  Pranav Puri, Jennifer Carroll,
Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Peter K. Smith, MD, Robert M. Califf, MD, Robert H
Impact of Intravenous P2Y12-Receptor Inhibition with Cangrelor in Patients Presenting with Acute Coronary Syndrome and Cardiogenic Shock – a.

Impact of Intravenous P2Y12-Receptor Inhibition with Cangrelor in Patients Presenting with Acute Coronary Syndrome and Cardiogenic Shock – a.
Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:

Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:
Volume 81, Issue 10, Pages (October 2010)

Volume 81, Issue 10, Pages (October 2010)
Copyright © 2005 American Medical Association. All rights reserved.

Copyright © 2005 American Medical Association. All rights reserved.
Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.

Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.
Fig. 2.The 24-hour urine sodium excretion compared according to the number of metabolic syndrome factors. In all subjects, a significant relationship was.

Fig. 2.The 24-hour urine sodium excretion compared according to the number of metabolic syndrome factors. In all subjects, a significant relationship was.
Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE.

Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE.
Abela M, Lentini F, Gatt A, Felice Malta Medial School Conference 2012

Abela M, Lentini F, Gatt A, Felice Malta Medial School Conference 2012
Circ Cardiovasc Interv

Circ Cardiovasc Interv
Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype status. Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype.

Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype status. Prasugrel or ticagrelor selection by clinical factor and CYP2C19 phenotype.
Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.

Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.

Similar presentations

Ads by Google